美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=CHLORDIAZEPOXIDE HYDROCHLORIDE"
符合检索条件的记录共64
7 页 当前第 5 页  首页 上一页 下一页 最后一页 返回检索页
41药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086294产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格10MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WATSON LABORATORIES INC
42药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086382产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WATSON LABORATORIES INC
43药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086383产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WATSON LABORATORIES INC
44药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086494产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构TEVA PHARMACEUTICALS USA INC
45药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086876产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格10MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
46药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086892产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
47药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号086893产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
48药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号087037产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格10MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
49药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号087231产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
50药品名称CHLORDIAZEPOXIDE HYDROCHLORIDE
申请号087234产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO